Erica M Stringer

No ORCID on file · 2 papers in corpus
review 2013
Oncology & hematology review ·doi:10.17925/ohr.2013.09.1.41

Hormonal therapies such as progestins have only modest activity in the treatment of advanced endometrial cancer. Mechanisms of resistance to progestin therapy are not well understood. However, activation of the PI3K/AKT/mTOR pathway has bee…

review 2010
European endocrinology ·doi:10.17925/ee.2013.09.01.18

Hormonal therapies such as progestins have only modest activity in the treatment of advanced endometrial cancer. Mechanisms of resistance to progestin therapy are not well understood. However, activation of the PI3K/AKT/mammalian target of …